BUSINESS ACQUISITIONS (Tables)

12 Months Ended

Dec. 31, 2016

The following tables summarize the total consideration and the amounts of assets acquired and liabilities assumed for Solstas Lab Partners Group and Summit Health, Inc. acquisitions, which are further discussed below:



	Solstas		Summit Health

Cash	$	572	$	125
Estimated fair value of contingent consideration	—		22
Transaction related costs due to sellers	—		5
Total consideration	$	572	$	152



	Solstas			Summit Health
	Fair Value		Weighted Average Useful Life (in years)	Fair Value		Weighted Average Useful Life (in years)
Allocation of purchase price:
Cash and cash equivalents	$	9		$	1
Accounts receivable, net	48			9
Other current assets	12			16
Property, plant and equipment, net	49			6
Goodwill	271			92
Intangible assets:
Customer relationships	203		20	33		15
Tradename	7		2	2		1
Software	—			3		4
Total intangible assets	210			38
Non-current deferred income taxes	48			—
Total assets acquired	647			162
Current liabilities	64			10
Non-current deferred income taxes	3			—
Other non-current liabilities	8			—
Total liabilities assumed	75			10
Net assets acquired	$	572		$	152

Schedule of Pro Forma Information

Pre-acquisition financial information for all other acquisitions has not been included in the table below as these acquisitions were not material to the Company’s consolidated financial statements.



	2014
	(unaudited)
Pro forma net revenues	$	7,520

Pro forma income from continuing operations	$	585

Earnings per share attributable to Quest Diagnostics’ common stockholders - basic:
Pro forma income from continuing operations	$	3.79

Earnings per share attributable to Quest Diagnostics’ common stockholders - diluted:
Pro forma income from continuing operations	$	3.77